Illuminating Progress: Exploring the Global Photodynamic Therapy Market

November 07, 2023 01:45 AM AEDT | By EIN Presswire
 Illuminating Progress: Exploring the Global Photodynamic Therapy Market
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, November 6, 2023 /EINPresswire.com/ -- The global photodynamic therapy market, valued at $4.58 billion in 2022, is anticipated to reach $5.29 billion in 2023, showcasing a notable compound annual growth rate (CAGR) of 15.5%. Despite the disruptive impact of the Russia-Ukraine conflict on the global economic recovery from the COVID-19 pandemic, the market is projected to exhibit robust growth, with an estimated market size of $9.35 billion by 2027, boasting a CAGR of 15.3%.

Market Segmentation and Key Dynamics

• Product: Drugs, Devices
• Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
• End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Leading photodynamic therapy market players such as Hologic Inc. and Biofrontera AG are actively driving the advancement of the photodynamic therapy industry through strategic research and development initiatives and innovative product launches.

To explore the market landscape further, view a sample report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Market Drivers and Current Trends

The escalating prevalence of skin cancer is significantly contributing to the growth of the photodynamic therapy market. Skin cancer, the most prevalent of all cancers, especially poses a significant public health challenge. Photodynamic therapy (PDT) has emerged as a promising treatment option, utilizing a combination of light-sensitizing medication and intense light to effectively target and destroy cancer cells. As per the American Cancer Society, it is estimated that approximately 106,110 new melanomas will be diagnosed in the United States in 2021, underscoring the urgent need for advanced treatment solutions in the field of photodynamic therapy.

Innovations Steering Industry Advancements

Industry players are increasingly focusing on conducting clinical trials to explore the efficacy of photodynamic therapy in conjunction with different drugs. Notably, Biofrontera Inc., a prominent biopharmaceutical company based in the United States, recently announced the initiation of Phase 1 trials to evaluate the safety and tolerability of photodynamic therapy (PDT) for the treatment of actinic keratosis (AK). The therapy involves the utilization of Ameluz® and the brand-new BF-RhodoLED® XL lamp for the management of mild-to-severe actinic keratosis (AK) on the face and scalp, emphasizing the critical role of innovation in addressing pressing healthcare challenges.

Regional Analysis and Future Prospects

With North America emerging as the largest region in the photodynamic therapy market in 2022, the comprehensive market report encompasses a detailed analysis of key regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

For a comprehensive understanding of the evolving dynamics within the global photodynamic therapy market, access the complete market report:
https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Photodynamic Therapy Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Photodynamic Therapy Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on photodynamic therapy market size, photodynamic therapy market drivers and trends, photodynamic therapy market major players, photodynamic therapy market competitors' revenues, photodynamic therapy market positioning, and photodynamic therapy market growth across geographies. The photodynamic therapy market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Oncology Biosimilars Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Oncology Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Oncology Molecular Diagnostics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.